🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

7 recruiting trials

for Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)

A Study of Rocbrutinib Combined With R-GemOx in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma NCT07570017Phase 12 sites📍 Guangzhou📍 Shanghai Guangzhou Lupeng Pharmaceutical Company LTD. · Tests: Rocbrutinib, R-GemOx Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL NCT04502394Phase 1, Phase 245 sites📍 Goshen📍 Cincinnati📍 Columbus Kartos Therapeutics, Inc. · Tests: KRT-232, acalabrutinib Enhancing CAR-T Cell Therapy Efficacy in B-cell Lymphoma Via Chidamide and PD-1 Inhibitor Combination. NCT07489989Phase 21 site📍 Beijing Daihong Liu · Tests: CAR-T Cell Therapy + Chidamide and PD-1 Inhibitor Maintenance IOMAB-CAR-T Followed by CAR-T Cell Therapy in R/R DLBCL NCT06768905Phase 1, Phase 21 site📍 Dallas University of Texas Southwestern Medical Center · Tests: Iomab-B, CAR-T cell Pirtobrutinib, Lisaftoclax, and Rituximab in the Treatment of R/R DLBCL NCT07255963Phase 21 site📍 Suzhou The First Affiliated Hospital of Soochow University · Tests: Pirtobrutinib, Lisaftoclax, Rituximab Phase I-II Study in CD30 Positive Diffuse Large B-cell Lymphoma Patients Refractory to First Line Chemotherapy or in First Relapse NCT03356054Phase 1, Phase 21 site📍 Rotterdam Stichting Hemato-Oncologie voor Volwassenen Nederland · Tests: R-DHAP, Brentuximab Vedotin Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL NCT06806033Phase 253 sites📍 Anchorage📍 Clovis📍 Fullerton Hoffmann-La Roche · Tests: Obinutuzumab, Glofitamab, Gemcitabine, Oxaliplatin
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy